Page 96 - Read Online
P. 96

Page 10 of 11                                           Wilson et al. Hepatoma Res 2020;6:57  I  http://dx.doi.org/10.20517/2394-5079.2020.48

               Financial support and sponsorship
               None.


               Conflicts of interest
               Wilson SR reports equipment support from Siemens, Samsung and Philips. Wilson SR reports a research
               grant from Samsung. Merrill C declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Romanini L, Passamonti M, Aiani L, Cabassa P, Raieli G, et al. Economic assessment of contrast-enhanced ultrasonography for
                   evaluation of focal liver lesions: a multicentre Italian experience. Eur Radiol 2007;17 Suppl 6:F99-106.
               2.   Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, et al. Guidelines and good clinical practice recommendations for contrast
                   enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB,
                   AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013;34:11-29.
               3.   Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, et al; World Federation for Ultrasound in Medicine. European Federation of
                   Societies for Ultrasound. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver
                   - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
                   Ultrasound Med Biol 2013;39:187-210.
               4.   Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, et al. The EFSUMB Guidelines and Recommendations on the Clinical
                   Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012;33:33-59.
               5.   Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents.
                   The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006;32:1369-75.
               6.   Darge K, Papadopoulou F, Ntoulia A, Bulas DI, Coley BD, et al. Safety of contrast-enhanced ultrasound in children for non-cardiac
                   applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS). Pediatr
                   Radiol 2013;43:1063-73.
               7.   Schwarze V, Marschner C, Negrão de Figueiredo G, Rübenthaler J, Clevert DA. Single-center study: evaluating the diagnostic
                   performance and safety of contrast-enhanced ultrasound (CEUS) in pregnant women to assess hepatic lesions. Ultraschall Med
                   2020;41:29-35.
               8.   Averkiou M. Nonlinear pulsing schemes for the detection of ultrasound contrast agents. Available from: https://www.academia.
                   edu/25447720/Nonlinear_pulsing_schemes_for_the_detection_of_ultrasound_contrast_agents. [Last accessed on 13 Aug 2020].
               9.   Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with
                   microbubble contrast. Invest Radiol 2000;35:58-71.
               10.  Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans
                   and MR images. Radiology 2007;242:162-74.
               11. Wilson SR, Kim TK, Jang HJ, Burns PN. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography
                   and contrast-enhanced CT and MRI. AJR Am J Roentgenol 2007;189:W7-12.
               12. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion
                   sonography. AJR Am J Roentgenol 2006;186:1401-12.
               13. Lyshchik A, Kono Y, Dietrich CF, Jang HJ, Kim TK, et al. Contrast-enhanced ultrasound of the liver: technical and lexicon
                   recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY) 2018;43:861-79.
               14.  Burns PN, Wilson SR. Microbubble contrast for radiological imaging: 1. Principles. Ultrasound Q 2006;22:15-8.
               15.  Strobel D, Seitz K, Blank W, Schuler A, Dietrich C, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions--
                   diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008;29:499-505.
               16.  Friedrich-Rust M, Klopffleisch T, Nierhoff J, Herrmann E, Vermehren J, et al. Contrast-Enhanced Ultrasound for the differentiation of
                   benign and malignant focal liver lesions: a meta-analysis. Liver Int 2013;33:739-55.
               17.  Bhayana D, Kim TK, Jang HJ, Burns PN, Wilson SR. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of
                   washout. AJR Am J Roentgenol 2010;194:977-83.
               18.  Sporea I, Martie A, Bota S, Sirli R, Popescu A, et al. Characterization of focal liver lesions using contrast enhanced ultrasound as a first
   91   92   93   94   95   96   97   98   99   100   101